CPS2, a pioneering compound, is a potent, selective, and irreversible PROTAC CDK2 degrader, marking a significant advancement in this class of molecules. This innovative agent, CPS2, holds promise for research applications in the study of acute myeloid leukemia.
Usually ships within 24 hours.